A$5m Initial Public Offering

March 2005

Phylogica, a leading biotechnology company with unique peptide technology, was created by the Telethon Institute for Child Health Research led by Australian of the Year, Fiona Stanley. Azure Capital was the lead adviser to Phylogica in structuring the spin-out of the company from the Institute and managed the subsequent IPO.